The Core Benefits of Microdosing Liver and Cardiovascular Protection A 72-week trial found 40% of patients achieved resolution of fatty liver disease without worsening fibrosis. In animal models, GLP-1s suppress fat production in the liver and reduce inflammation. Tirzepatide at low doses showed particularly strong cardiovascular benefits, with meaningful improvements across multiple lipid markers linked to heart disease risk. Cholesterol storage forms increased far less with tirzepatide, and harmful lipids like ceramides showed minimal increase compared to placebo
Greenberg T, Bertocci MA, Versace A, Lima Santos JP, Chase HW, Siffler R, et al
We think Roches pharmaceutical innovation and diagnostics dominance support a wide moat
Ngoei KRW, Langendorf CG, Ling NXY, Hoque A, Varghese S, Camerino MA, et al
The upper arm specifically refers to the back of the upper arm in the fatty tissue area